Edition:
United States

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

19.47USD
23 May 2019
Change (% chg)

-- (--)
Prev Close
$19.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
94,666
52-wk High
$24.78
52-wk Low
$11.45

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

No Ratios Available.

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -- -- --
ROI: -- 14.23 13.82
ROE: -- 15.46 15.24

Earnings vs. Estimates